{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T20:32:23Z","timestamp":1785616343841,"version":"3.56.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:p>Reversal of gender-discriminatory insurance coverage policies has led to a substantial increase in access to gender-affirming surgical care in the United States over the past 20 years. Although the evidence supports the safety, feasibility, and medical necessity of gender-affirming hysterectomy and oophorectomy, there are currently no evidence-based guidelines to define optimal care surrounding many aspects of these surgeries. This commentary reviews the evidence supporting the safety, feasibility, and route of hysterectomy and oophorectomy for transgender men, the benefits and risks of oophorectomy in cisgender women and their extrapolation to transgender men, and the effects of testosterone supplementation in transgender men with and without ovaries. In addition, this article highlights the data gaps surrounding whether oophorectomy should be performed at the time of hysterectomy. Oophorectomy in cisgender women is associated with negative outcomes such as an increase in cardiovascular events and all-cause mortality, most likely attributable to attenuated estrogen levels. There are insufficient outcomes data regarding oophorectomy in transgender men to make the same inference about potential morbidity and mortality. Areas for future research to elucidate best practices are identified in the context of the increasing number of gender-affirming surgeries. As physicians, it is our duty to provide transgender patients with evidence-based recommendations on gynecologic gender-affirming care and to avoid any potential harm.<\/jats:p>","DOI":"10.1097\/aog.0000000000003472","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T11:43:25Z","timestamp":1568115805000},"page":"714-717","source":"Crossref","is-referenced-by-count":38,"title":["Barriers to Evidence-Based Transgender Care"],"prefix":"10.1097","volume":"134","author":[{"given":"Zachary P.","family":"Reilly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothee F.","family":"Fruhauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/jamasurg.2017.6231","article-title":"Temporal trends in gender-affirming surgery among transgender patients in the United States","volume":"153","author":"Canner","year":"2018","journal-title":"JAMA Surg"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1097\/AOG.0b013e31823ed1c1","article-title":"Health care for transgender individuals. Committee Opinion No. 512. American College of Obstetricians and Gynecologists","volume":"118","year":"2011","journal-title":"Obstetrics Gynecol"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/01.AOG.0000286778.44943.5a","article-title":"Total laparoscopic hysterectomy for female-to-male transsexuals","volume":"110","author":"O'Hanlan","year":"2007","journal-title":"Obstetrics Gynecol"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/s-0030-1269941","article-title":"Vaginale Hysterektomie und bilaterale Adnexektomie in interdisziplin\u00e4rem Konzept bei Female-to-Male (FtM) Transsexualismus","volume":"70","author":"Kaiser","year":"2010","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/AOG.0000000000001866","article-title":"Feasibility of vaginal hysterectomy for female-to-male transgender men","volume":"129","author":"Obedin-Maliver","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/AOG.0000000000002936","article-title":"Complication rates and outcomes after hysterectomy in transgender men","volume":"132","author":"Bretschneider","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jmig.2017.09.008","article-title":"Hysterectomy for the transgendered male: review of perioperative considerations and surgical techniques with description of a novel 2-port laparoscopic approach","volume":"25","author":"Marfori","year":"2018","journal-title":"J Minim Invasive Gynecol"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jmig.2018.04.022","article-title":"Transvaginal natural orifice transluminal endoscopic surgery for female-to-male transgender men","volume":"26","author":"Lee","year":"2019","journal-title":"J Minim Invasive Gynecol"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/AOG.0b013e31828e89df","article-title":"Risk of oophorectomy after hysterectomy","volume":"121","author":"Casiano","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ygyno.2005.01.030","article-title":"Hysterectomy with or without unilateral oophorectomy and risk of ovarian cancer","volume":"97","author":"Chiaffarino","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S1470-2045(06)70869-5","article-title":"Survival patterns after oophorectomy in premenopausal women: a population-based cohort study","volume":"7","author":"Rocca","year":"2006","journal-title":"Lancet Oncol"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/01.ogx.0000433842.26579.00","article-title":"Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study","volume":"68","author":"Parker","year":"2013","journal-title":"Obstet Gynecol Surv"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.accreview.2005.06.026","article-title":"Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy","volume":"14","author":"Howard","year":"2005","journal-title":"ACC Curr J Rev"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000211951","article-title":"Increased mortality for neurological and mental diseases following early bilateral oophorectomy","volume":"33","author":"Rivera","year":"2009","journal-title":"Neuroepidemiology"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/GME.0000000000000506","article-title":"Cardiovascular risk factors and diseases in women undergoing hysterectomy with ovarian conservation","volume":"23","author":"Laughlin-Tommaso","year":"2016","journal-title":"Menopause"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/AOG.0000000000001592","article-title":"Salpingo-oophorectomy at the time of benign hysterectomy","volume":"128","author":"Evans","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/15532739.2011.700873","article-title":"Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7","volume":"13","author":"Coleman","year":"2012","journal-title":"Int J Transgenderism"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/00006534-200003000-00063","article-title":"Ought GIDNOS get nought? Treatment options for nontranssexual gender dysphoria","volume":"105","author":"Hage","year":"2000","journal-title":"Plast Reconstr Surg"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1111\/1471-0528.15258","article-title":"Breast and reproductive cancers in the transgender population: a systematic review","volume":"125","author":"Joint","year":"2018","journal-title":"BJOG"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4158\/EP-2017-0203","article-title":"Estrogen levels do not rise with testosterone treatments for transgender men","volume":"24","author":"Chan","year":"2018","journal-title":"Endocr Pract"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.rbmo.2017.03.008","article-title":"Ovarian tissue cryopreservation in female-to-male transgender people: insights into ovarian histology and physiology after prolonged androgen treatment","volume":"34","author":"De Roo","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/jc.2005-2430","article-title":"Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome","volume":"91","author":"Lo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/humrep\/del474","article-title":"Association between polycystic ovary syndrome and female-to-male transsexuality","volume":"22","author":"Baba","year":"2007","journal-title":"Hum Reprod"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0026-0495(89)90233-3","article-title":"Mortality and morbidity in transsexual patients with cross-gender hormone treatment","volume":"38","author":"Asscheman","year":"1989","journal-title":"Metab Clin Exp"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/EJE-10-1038","article-title":"A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones","volume":"164","author":"Asscheman","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"R27-20230711","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2265.1997.2601068.x","article-title":"Mortality and morbidity in transsexual subjects treated with cross-sex hormones","volume":"47","author":"van Kesteren","year":"1997","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003472","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:59:02Z","timestamp":1689105542000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003472"}},"subtitle":["Knowledge Gaps in Gender-Affirming Hysterectomy and Oophorectomy"],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000003472","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}